Literature Review

Chromosomal Deletion May Increase the Risk of Parkinson’s Disease

Neurology Reviews. 2016 May;24(5):24

 

References

—Jake Remaly

Pages

Recommended Reading

Drug targeting Huntington’s disease–causing protein undergoing clinical trial
MDedge Neurology
Opicapone May Reduce Off Time for Patients With Parkinson’s Disease
MDedge Neurology
Rosacea linked to increased Parkinson’s disease risk
MDedge Neurology
Tips for Living With Essential Tremor
MDedge Neurology
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
MDedge Neurology
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
MDedge Neurology
AAN updates botulinum toxin guidelines for most established uses
MDedge Neurology
Valbenazine Reduces Tardive Dyskinesia Severity
MDedge Neurology
AAN Updates Guidelines on Use of Botulinum Toxin for Four Disorders
MDedge Neurology
Extended-release amantadine may improve levodopa dyskinesia control
MDedge Neurology

Related Articles